What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q1 2026?

37 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q1 2026. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 5,437,973
Share change: +976,538
Total reported value: $4,350,269
Price per share: $0.80
Number of holders: 37
Value change: +$631,162
Number of buys: 17
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Rubric Capital Management LP	13F 13D/G 3/4/5	Company · 10%+ Owner	16% from 13D/G	30,046,828	$39,060,876	—	31 Dec 2025	13F 13D/G 3/4/5
Clearline Capital LP	13D/G 13F	Company	6.7%	12,235,239	$18,108,154	+$3,733,614	31 Dec 2025	13D/G 13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	6.1%	11,185,325	$14,540,923	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	5.6%	10,218,236	$13,283,708	—	31 Dec 2025	13F
VANGUARD GROUP INC	13F	Company	5.4%	9,820,384	$12,766,499	—	31 Dec 2025	13F
Adam Morgan	3/4/5	Director	— mixed-class rows	8,982,939 mixed-class rows	$11,602,242	+$2,649,819	30 Jan 2026	3/4/5
Velan Capital Investment Management LP	13F 3/4/5	Company · Other*	4.8%	8,753,290	$11,379,277	—	31 Dec 2025	13F 3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	3.9%	7,169,908	$9,320,880	—	31 Dec 2025	13F
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	3.5%	6,326,113	$8,223,947	—	31 Dec 2025	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	3.4%	6,250,000	$8,125,000	—	31 Dec 2025	13F
Tejara Capital Ltd	13F	Company	2.8%	5,131,426	$6,670,854	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.2%	4,081,222	$5,306,435	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	2.1%	3,778,043	$4,911,456	—	31 Dec 2025	13F
JW Asset Management, LLC	13F	Company	2%	3,671,073	$4,772,395	—	31 Dec 2025	13F
Congress Park Capital LLC	13F	Company	1.7%	3,067,475	$3,987,718	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	1.6%	3,004,640	$3,906,032	—	31 Dec 2025	13F
Focus Partners Wealth	13F	Company	0.08%	148,470	$3,570,536	—	31 Dec 2025	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	1.4%	2,576,716	$3,349,731	—	31 Dec 2025	13F
Mark E. Hensley	3/4/5	Chief Operating Officer	— mixed-class rows	1,776,629 mixed-class rows	$3,080,000	—	30 Jan 2026	3/4/5
CITADEL ADVISORS LLC	13F	Company	1.1%	2,095,045	$2,723,559	—	31 Dec 2025	13F
UBS Group AG	13F	Company	1.1%	2,091,669	$2,719,170	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1%	1,915,900	$2,490,670	—	31 Dec 2025	13F
Barry D. Quart	3/4/5	Chief Executive Officer, Director	— mixed-class rows	1,142,796 mixed-class rows	$2,142,511	—	18 Jan 2023	3/4/5
Pale Fire Capital SE	13F	Company	0.8%	1,469,655	$1,910,552	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.78%	1,415,336	$1,839,937	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.75%	1,367,891	$1,778,259	—	31 Dec 2025	13F
Stonepine Capital Management, LLC	13F	Company	0.68%	1,237,802	$1,609,143	—	31 Dec 2025	13F
Monaco Asset Management SAM	13F	Company	0.68%	1,233,022	$1,602,929	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.6%	1,091,411	$1,418,835	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.55%	999,509	$1,299,362	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.54%	989,796	$1,286,735	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.53%	963,851	$1,253,007	—	31 Dec 2025	13F
Kevin Kotler	3/4/5	Director	— class O/S missing	577,879	$1,242,440	—	22 Feb 2023	3/4/5
CM Management, LLC	13F	Company	0.41%	750,000	$975,000	—	31 Dec 2025	13F
Orchard Capital Management, LLC	13F	Company	0.37%	680,432	$884,562	—	31 Dec 2025	13F
Squarepoint Ops LLC	13F	Company	0.37%	677,947	$881,331	—	31 Dec 2025	13F
Richmond Brothers, Inc.	13F	Company	0.31%	572,118	$743,755	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.28%	519,571	$675,442	—	31 Dec 2025	13F
NEXPOINT ASSET MANAGEMENT, L.P.	13F	Company	0.26%	475,750	$618,475	—	31 Dec 2025	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.24%	440,252	$572,328	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.23%	418,477	$544,020	—	31 Dec 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.21%	376,300	$489,189	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	0.19%	347,065	$451,185	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.19%	340,246	$442,320	—	31 Dec 2025	13F
Invesco Ltd.	13F	Company	0.17%	307,861	$400,220	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.17%	303,209	$394,172	—	31 Dec 2025	13F
Apeiron RIA LLC	13F	Company	0.14%	259,968	$358,756	—	31 Dec 2025	13F
Palumbo Wealth Management LLC	13F	Company	0.14%	259,413	$337,237	—	31 Dec 2025	13F
Cyndeo Wealth Partners, LLC	13F	Company	0.14%	248,087	$322,513	—	31 Dec 2025	13F
Thomas Cusack	3/4/5	Director	— mixed-class rows	281,232 mixed-class rows	$320,147	—	30 Jan 2026	3/4/5

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q1 2026

As of 31 Mar 2026, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,437,973 shares. The largest 10 holders included Congress Park Capital LLC, Nuveen, LLC, Apeiron RIA LLC, COMMONWEALTH EQUITY SERVICES, LLC, Prospera Financial Services Inc, Police & Firemen's Retirement System of New Jersey, R Squared Ltd, HSBC HOLDINGS PLC, Concurrent Investment Advisors, LLC, and ACT Advisors, LLC.. This page lists 37 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

169

Q1 2026 holders

Holder diff

-132

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.